Human H3N2 influenza A viruses were known to preferentially bind to sialic acid (SA) in ␣2,6Gal linkage on red blood cells (RBC). However, H3N2 viruses isolated in MDCK cells after 1992 did not agglutinate chicken RBC (CRBC). Experiments with point-mutated hemagglutinin (HA) of A/Aichi/51/92, one of these viruses, revealed that an amino acid change from Glu to Asp at position 190 (E190D) was responsible for the loss of ability to bind to CRBC. A/Aichi/51/92 did not agglutinate CRBC treated with ␣2,3-sialidase, suggesting that SA␣2,3Gal on CRBC might not inhibit the binding of the virus to SA␣2,6Gal on CRBC. However, the virus agglutinated derivatized CRBC resialylated with SA␣2,6Gal␤1,4GlcNAc. These findings suggested that the E190D change might have rendered the HA able to distinguish sialyloligosaccharides on the derivatized CRBC containing the SA␣2,6Gal␤1,4GlcNAc sequence from those on the native CRBC.
INTRODUCTION
The receptor-binding specificity of a virus is significant in determining the range of hosts which a virus can infect or the degree of tissue tropism which a virus can display. Terminal sialic acids of sialylglycoproteins and gangliosides are known to be receptor determinants for influenza viruses (Gottschalk, 1959) . Influenza virus infection is initiated by interactions between viral glycoprotein, hemagglutinin (HA), and sialic acid moieties of glycoconjugates on host cells (reviewed in Wiley and Skehel, 1987) . The interaction between sialic acids on target cells and HA is occasionally influenced by sialic acids on HA. Ohuchi et al. (1995) indicated that sialic acids on oligosaccharides close to the receptor-binding site of HA interfered with the binding of HA to erythrocytes. On the other hand, the receptor binding of influenza viruses is occasionally dependent on the manner in which a sialic acid is linked to the penultimate galactose, that is, whether the sialic acid is in ␣2,3Gal linkage (SA␣2,3Gal) or ␣2,6Gal linkage (SA␣2,6Gal). The preferential binding of the viruses to erythrocytes derivatized with sialyltransferase was used to estimate the binding specificity to SA␣2,3Gal or SA␣2,6Gal Connor et al., 1994) .
Human influenza A viruses (H3N2) isolated in MDCK cells after 1992 are no longer able to agglutinate chicken red blood cells (CRBC) (ChϪ viruses), but do agglutinate human RBC (HRBC), as is shown in this study. We previously reported two phenotypes of H1N1 human influenza A viruses isolated after 1991, one of which agglutinated CRBC, whereas the other did not (Morishita et al., 1993) . Both viruses were in cocirculation in the 1991/1992 and 1995/1996 seasons, and neither was predominant (Morishita et al., 1997) . After the cells infected with the latter group of H1N1 viruses were treated with a bacterial sialidase, these cells acquired the ability to hemadsorb chicken erythrocytes, suggesting that interference by sialic acids on HA was one reason why hemagglutination of CRBC was not observed (Tong et al., 1998) . In contrast to H1N1, the ChϪ type of H3N2 viruses has become the major form of circulating H3N2 since the 1992/1993 season. This altered receptor-binding ability has been retained for 8 years among the predominant H3N2 viruses in circulation. In this study, to elucidate the mechanism by which ChϪ viruses underwent this alteration in receptor-binding ability, we examined the receptor binding of site-specific mutated HAs of ChϪ virus and characterized sialic acids on both native and derivatized RBC.
RESULTS

Characterization of ChϪ viruses
Human influenza A viruses isolated in MDCK cells after 1992 in Japan could not agglutinate CRBC. The hemagglutination titers of the following viruses were examined: ChϪ viruses, A/Aichi/51/92 (51/92), A/Aichi/ 48/93 (48/93), A/Aichi/18/95 (18/95), A/Aichi/46/96 (46/ 96), A/Aichi/30/97 (30/97), A/Aichi/11/98 (11/98), and A/Aichi/3/99 (3/99), all of which are representatives of consecutive influenza seasons from 1992 to 1999, and two other viruses, A/Aichi/2/68 (AI/68) and A/Chiang Mai/ 156/88 (CM/88), both of which agglutinate CRBC (Chϩ viruses) and were used for reference. All of the ChϪ viruses agglutinated HRBC at hemagglutination titers of 64 to 128, but did not agglutinate CRBC. In contrast, Chϩ viruses agglutinated both kinds of erythrocytes at hemagglutination titers of 128.
Three independent clones of each ChϪ virus were obtained by plaque purification in MDCK cells and used to confirm that the hemagglutination phenotype of ChϪ viruses was predominant in the respective virus isolates. Hemagglutination titers of the respective cloned viruses did not show hemagglutination ability toward CRBC but did show hemagglutination ability to HRBC (as well as did their parent viruses), suggesting that the loss of CRBC hemagglutination was common but not a particular characteristic of a ChϪ virus population.
To examine whether the quantity of HA relative to amounts of other viral proteins on the virion was lower in ChϪ virus than in Chϩ virus, proteins of the purified viruses were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The ratios of the quantity of nucleoprotein to HA and M1 proteins of 51/92 or of 30/97 (ChϪ viruses) were almost equal to those of CM/88 (Chϩ virus). This suggested that the lack of hemagglutination of CRBC using ChϪ viruses could not be ascribed to a lower level of viral HA protein on the virion.
Hemadsorption of cells infected with ChϪ and Chϩ viruses was further compared. Figure 1 shows the hemadsorption of MDCK (Fig. 1a) and Cos (Fig. 1b) cells infected with 51/92 (Figs. 1a and 1b, panels A, panels B, and panels C), one of the ChϪ viruses, as well as of those infected with CM/88 (Figs. 1a and 1b, panels D and panels E) (Chϩ virus). When both kinds of cells were infected with 51/92, both adsorbed HRBC efficiently (Figs. 1a and 1b, panels A), but hemadsorption was undetectable with CRBC ( Figs. 1a and 1b, panels B) . On the other hand, cells infected with CM/88 adsorbed both kinds of erythrocytes (Figs. 1a and 1b, panels D and panels E). These results suggested that the feature of hemadsorption of Cos cells infected with 51/92 and CM/88 was equivalent to that of MDCK cells infected with the respective viruses. On the other hand, to avoid the interference by sialic acids on HA with hemadsorption, the cells infected with 51/92 were treated with Vibrio cholerae neuraminidase (VCNA). However, the VCNA treatment did not improve the hemadsorption of both types of the cells with CRBC (Figs. 1a and 1b, panels C) . The hemadsorption phenotype of the other ChϪ viruses examined was similar to that of 51/92. These results suggested that the loss of binding ability of ChϪ viruses to CRBC was neither a host-cell-specific characteristic nor the result of interference by sialic acids on the HA glycoconjugates.
Characterization of expressed HA proteins in Cos cells
To examine the molecular mechanism of the lack of hemagglutination ability of ChϪ viruses with CRBC, we compared the intrinsic receptor-binding ability of the HA of ChϪ and Chϩ viruses in the absence of the possible influence of other viral proteins. For this purpose, the HA of 51/92 (51-HA) and of CM/88 (CM-HA) were expressed on Cos cells using an expression vector, pME18S, as described under Materials and Methods. Cell-surface expression of expressed HA was confirmed by cell-surface immunofluorescence. Expressed 51-HA and CM-HA were detected on the cell surface at similar levels (Table with 51/92 (panels A, panels B, and panels C) and CM/88 (panels D and panels E). At 18 h postinfection, the cells were washed with medium and hemadsorption was tested with HRBC (panels A and panels D) and CRBC (panels B, panels C, and panels E). Prior to the hemadsorption assay, cells (C) were treated with VCNA (1 unit/ml) at 37°C for 1 h. Cells were observed under a phase-contrast microscope at 200ϫ magnification.
1). The receptor-binding capacity of each respective HA was estimated from its ability to hemadsorb the two types of RBC. Quantification of hemadsorption was performed by means of a hemolysis assay (Table 1) . Both HA types exhibited hemadsorption toward HRBC to an equal extent, although CM-HA could also adsorb CRBC while 51-HA could not (Table 1) . VCNA treatment of the cells expressing 51-HA did not improve the hemadsorption with CRBC. These results indicated that 51-HA had undergone an intrinsic loss in its ability to bind to CRBC.
Determination of the portion responsible for the inability of 51-HA to hemadsorb CRBC To determine the region within 51-HA that was responsible for the loss of binding ability to CRBC, we constructed three chimeras of 51-HA and CM-HA and expressed them on Cos cells as described under Materials and Methods (Fig. 2) . Chimera 1 consisted of 219 residues (1 to 219) of 51-HA and 348 residues (220 to 567) of CM-HA, chimera 2 consisted of 186 residues (1 to 186) of 51-HA and 381 residues (187 to 567) of CM-HA, and chimera 3 contained 36 residues (186 to 219) of CM-HA in the corresponding region of 51-HA. All chimeric HAs were detected on the cell surface at levels equal to those of 51-HA and CM-HA (Table 1) . Chimeras 1 and 3 exhibited efficient hemadsorption with CRBC and HRBC as did CM-HA, but chimera 2 was able to adsorb only HRBC (Table 1 ). This result allowed us to narrow our search to the region between amino acid residues at positions 186 and 219. Subsequent sequence analysis showed that 51-HA and CM-HA are different by four amino acids in this region and these residues are at positions, 189, 190, 193, and 198. To determine the amino acid residue(s) responsible for the inability of 51-HA-infected cells to hemadsorb CRBC, we constructed 10 mutants of 51-HA (51-mut1 to mut5) and CM-HA (CM-mut1 to mut5) (Table 1) by site-specific mutagenesis and expressed them on Cos cells as described under Materials and Methods. Intracellular transport of all mutant HAs to the cell surface was analyzed by cell-surface immunofluorescence. Expressed 
FIG. 2.
HA chimeras between 51-HA and CM-HA. The nucleotide sequences of 51-HA cDNA were replaced with sequences of the corresponding region of CM-HA cDNA using shared restriction enzyme sites to generate three chimeric HAs (Chimeras 1-3). The amino acid numbering system used was in accordance with that used for A/Aichi/ 2/68 (Wilson et al., 1981) .
HAs were observed on the surface of cells at almost equal levels (Table 1) . Hemadsorption ability was analyzed by means of a hemolysis assay (Table 1) . 51-HA and all of its mutants exhibited almost the same levels of hemadsorption with HRBC. 51-mut2, -mut3, and -mut4 acquired an ability to hemadsorb CRBC at a level similar to that of CM-HA, while 51-mut1 and -mut5 did not. 51-mut2, -mut3, and -mut4 shared an amino acid substitution at position 190 from Asp to Glu. In contrast, CMmut2, -mut3, and -mut4, all of which have an amino acid change at position 190 from Glu to Asp, appeared incapable of CRBC hemadsorption. Hemadsorption of HRBC with these mutants was half that of CM-HA. CM-mut1 and -mut5 showed nearly the same hemadsorption ability as that of CM-HA, although hemadsorption of CRBC with CM-mut5 was slightly decreased. These results indicated that Asp, instead of Glu, at position 190 had an inhibitory effect on the binding ability of 51-HA and CM-HA to CRBC, suggesting that the lack of detection of CRBC hemagglutination using 51/92 could be ascribed to Asp 190. Furthermore, Asp 190 of CM-mut2, -mut3, and -mut4 slightly abrogated the binding ability of these mutant HAs to HRBC, even though that of 51-HA did not. Since the amino acid residues surrounding the receptorbinding sites of CM-HA are not necessarily the same as those of 51-HA, Asp 190 may conceivably have a slightly different effect on the receptor-binding ability of the respective HAs.
Characterization of sialic acids on RBC
To compare HRBC and CRBC in terms of the species and amounts of sialic acid on their surfaces, we employed a method using sialidase and high-performance liquid chromatography (HPLC), as described under Materials and Methods. With this approach, sialic acid residues of oligosaccharides on the cell surface of these erythrocytes were released and analyzed by HPLC. The sialic acids released from CRBC and HRBC by bacterial sialidase from Vibrio cholerae and Arthrobacter were all N-acetylneuraminic acids (NeuAc), and N-glycolylneuraminic acids were not detected. The amount of NeuAc on RBC was calculated from the height of the peak for the NeuAc standard. The average total sialic acid content was 617 and 325 nmol/ml for packed HRBC and CRBC, respectively (Table 2) . On the other hand, the average amount of NeuAc in ␣2,3 linkage cleaved by ␣2,3-sialidase of Salmonella typhimurium LT2 and Newcastle disease virus was 177 and 182 nmol/ml for packed HRBC and CRBC, respectively (Table 2) . These results indicated that the ratio of NeuAc in ␣2,3 linkage to that of total NeuAc was higher in CRBC (56%) than in HRBC (28%). Using linkage-specific lectins and fluorescenceactivated cell sorting, Ito et al. (1997a) compared ratios of sialic acids in ␣2,3 linkage to those in ␣2,6 linkage in both types of erythrocytes and showed that the ratio was slightly higher in CRBC than in HRBC. In this study, we did not directly examine the amount of sialic acid in ␣2,6 linkage since ␣2,6-sialidase was not available. However, according to the results of Ito et al. (1997a) , most of the sialic acids, other than those in ␣2,3 linkage, might be in ␣2,6 linkage. Gambaryan et al. (1997) previously reported that H3N2 human influenza viruses isolated in MDCK cells exhibited high affinity for sialic acids in ␣2,6 linkage. To clarify whether the abundance of sialic acids in ␣2,3 linkage on CRBC inhibited the binding ability of 51/92 to sialic acids in ␣2,6 linkage, we compared the ability of 51/92 and CM/88 to agglutinate CRBC from which sialic acids in ␣2,3 linkage had been removed by ␣2,3-sialidase from Salmonella typhimurium LT2. Viruses that agglutinated HRBC with an HA titer of 64 to 128 were used in the following experiments. As shown in Fig. 3 , CM/88 agglutinated these CRBC with an HA titer of 64 to 128 (Fig. 3c) , which is similar to that with native CRBC (Fig. 3a) . In contrast, 51/92 failed to agglutinate these cells (Figs. 3a and 3c) . To determine the binding characteristics of the viruses to sialic acid in ␣2,3 or ␣2,6 linkage, we prepared derivatized CRBC resialylated with SA␣2,6Gal␤1,4GlcNAc and SA␣2,3Gal␤1,3/4GlcNAc by sialyltransferase, as described under Materials and Methods. 51/92 and CM/88 did not agglutinate VCNA-treated asialo CRBC (Fig. 3b ) or those resialylated with SA␣2,3Gal␤1,3/ 4GlcNAc (Fig. 3d) , but did agglutinate those resialylated with SA␣2,6Gal␤1,4GlcNAc (Fig. 3e) , although the amount of incorporated sialic acids (average is 46 nmol/ml; Table 3 ) was lower than that present on native CRBC (Table 2) . Furthermore, both viruses agglutinated the derivatized CRBC which had been treated with ␣2,3-sialidase and then resialylated with ␣2,6-sialyltransferase (Fig. 3g) . On the other hand, 51/92 did not agglutinate CRBC which had been treated with ␣2,3-sialidase and then resialylated with ␣2,3-sialyltransferase, although CM/88 did (Fig. 3f) . CM/88 might bind to the authentic sialic acid remaining on CRBC after ␣2,3-sialidase treatment rather than to the incorporated SA␣2,3Gal␤1,3/4GlcNAc sequence. If the sialic acids were released from these resialylated CRBC by bacterial sialidase, either of the viruses no longer agglutinated these RBC.
Hemagglutination with derivatized RBC
Taking these results together, 51/92 exhibited preferential binding to the SA␣2,6Gal␤1,4GlcNAc sequence but not to SA␣2,3Gal␤1,3/4GlcNAc or to the authentic sialic acids on native CRBC. CM/88 exhibited a preference for binding to sialic acid in the ␣2,6 linkage of derivatized and native CRBC but not to the SA␣2,3Gal␤1,3/4GlcNAc sequence. The amount of sialic acids incorporated into the derivatized CRBC ranged from 8 to 30% that of native CRBC (Table 3) , which is similar in range to that observed in previous studies (Carroll et al., 1981; Paulson and Rogers, 1987) .
Phylogenetic study
On the basis of the amino acid sequences deduced from nucleotide sequences of HA1 genes, phylogenetic relationships among the human H3N2 influenza viruses isolated after 1988 were investigated. The phylogenetic analysis showed that an amino acid change from Glu to Asp at position 190 of H3 HA had occurred after 1991 and that Asp 190 was retained in the trunk lineage until 1999. There was a recent report of H3N2 human influenza viruses isolated in 1996/1997 bearing Glu 190 or Val 190 in the HA (Bush et al., 1999) . Neither of these changes was observed in our ChϪ viruses. We do not know whether these viruses agglutinated CRBC. In our previous study, however, we indicated that Asp 190 was retained in the trunk lineage of other recent H3N2 ChϪ human influenza viruses isolated from 1996 to 1999 (Sato et al., 2000) . We also confirmed the identity of nucleotide sequences of HA gene cDNA obtained from PCR products of clinical samples and those from plaque-purified viruses. 1, 2, 3 ). E, Sialic acid in ␣2,6 linkage on native CRBC; ‚, sialic acid in ␣2,3 linkage on native CRBC; F, SA␣2,6Gal␤1,4 GlcNAc sequence on derivatized CRBC; OE, SA␣2,3Gal␤1,3/4GlcNAc sequence on derivatized CRBC.
DISCUSSION
Receptor binding of viruses is sometimes restricted by the number of receptor determinants on the target cells. N-Acetyl-9-O-acetylneuraminic acid (Neu5,9Ac
2 ) is a receptor determinant for attachment of influenza C virus, coronavirus, and hemagglutinating encephalomyelitis virus to RBC (Rogers et al., 1986; Vlasak et al., 1988; Schultze et al., 1990) . HRBC and 1-day-old chicken erythrocytes bear few Neu5,9Ac 2 moieties, and the three above-mentioned viruses usually cannot agglutinate these erythrocytes. However, if the erythrocytes were resialylated with Neu5,9Ac 2 , they were agglutinated by these viruses, although the efficiency differed, depending on the amount of Neu5,9Ac 2 incorporated (Schultze et al., 1990) . In this case, the number of receptor determinants on the erythrocytes was a limiting factor for the agglutination capacity of the viruses. On the other hand, sialic acids in ␣2,6 linkage were detected on native CRBC and their amount on these cells was sufficient for agglutination by H3N2 human influenza viruses, such as A/Aichi/2/68, A/Udorn/302/72, and A/Victoria/3/75, which preferentially bind to sialic acids in this type of linkage (Connor et al., 1994; Ito et al., 1997a) . However, ChϪ virus did not agglutinate native CRBC, even though they did agglutinate derivatized CRBC, which contained a lower amount of sialic acid in the ␣2,6 linkage compared to that in native CRBC. Martin et al. (1998) reported that Y98F, a receptor-site mutant with weak receptor-binding ability, could not agglutinate suspensions of 0.7% turkey and human erythrocytes. However, Y98F could agglutinate dilute preparations of 0.3 and 0.5% RBC. As for ChϪ viruses, they were unable to agglutinate CRBC, even in 0.1, 0.3, and 0.5% suspensions, although they could agglutinate HRBC in suspensions as high as 1%. Therefore the receptor-binding ability of ChϪ viruses may not necessarily be weak, although the range of binding specificity might become increasingly narrow compared to that of previous viruses (Connor et al., 1994) . Eisen et al. (1997) described the structures of hemagglutinin (H3)-sialyloligosaccharide complexes, as determined by X-ray crystallography. These investigators indicated that the difference between the structures of a pentasaccharide with ␣2,6 linkage and a trisaccharide 2,6-sialyllactose complexes with HA. Their results suggested that the binding affinity of these receptor analogs to HA might be different, although both analogs had the same ␣2,6 linkage at terminal sialic acid. It was possible that the sialyloligosaccharides attached to the glycoconjugates have different conformations and exhibit different affinities to HAs from sialyloligosaccharides unbound to glycoconjugates.
In this study, to elucidate the preferred structure of the natural receptor molecule reactive with 51/92, we utilized derivatized RBC instead of free sialyloligosaccharides. The derivatized CRBC was prepared using sialyltransferases that generate the sequences SA␣2,6Gal␤1,4GlcNAc and SA␣2,3Gal␤1,3/4GlcNAc, which are commonly found as terminal sequences in N-linked oligosaccharides (Weinstein et al., 1982) . As demonstrated in Fig. 3 , both viruses, 51/92 (ChϪ) and CM/88 (Chϩ), agglutinated derivatized CRBC bearing SA␣2,6Gal␤1,4GlcNAc but not those bearing SA␣2,3Gal␤1,3/4GlcNAc, which showed preference in binding similar to that of previous H3N2 human influenza viruses (Connor et al., 1994) . However, these previous viruses including A/Aichi/2/68 could agglutinate native CRBC (Ito et al., 1997a) . On the other hand, Kurosawa et al. (1994) isolated cDNA encoding Gal␤1,4GlcNAc ␣2,6-sialyltransferase from chicken embryonic cDNA libraries. Therefore the SA␣2,6Gal␤1,4GlcNAc sequence could be characteristic of sialyloligosaccharides of native CRBC. Nevertheless, 51/92 did not agglutinate native CRBC, whereas CM/88 did. One possible explanation for this result is that the receptor determinant reactive with 51/92 might be not only the terminal sialic acid in ␣2,6Gal linkage but also the asialo portion of sialyloligosaccharides on CRBC.
Glu 190 of HA of the X-31 strain is located in a short ␣-helix forming the receptor-binding site (Wilson et al., 1981) and is conserved in the majority of HAs of all subtypes sequenced (Kawaoka et al., 1990; Nobusawa et al., 1991; Rhöm et al., 1995) . Although residue 190 of X-31 HA is hydrogen bonded to the 9-OH of sialic acid (Weis et al., 1988) , Martin et al. (1998) suggested that the Glu 190/9-OH interaction does not appear to be essential for the binding of the HA to HRBC because one of their receptor mutant HAs, E190A, had a greater capacity to bind to HRBC than did wild type HA; however, they did not examine the binding of the mutant to CRBC. In our study, Asp 190 also failed to abrogate the HRBC binding a The amount of incorporated sialic acid is deduced by subtracting the amount of sialic acid on respective sialidase treated-RBCs from that on derivatized RBC resialylated by the respective sialytransferase.
b Number of experiment corresponds to that in Fig. 3 . c Vibrio cholerae sialidase. d Gal␤1,4GlcNAc ␣2,6 sialyltransferase. e Gal␤1,3/4GlcNAc ␣2,3 sialyltransferase. f ␣2,3 sialidase from Salmonella typhimurium LT2.
ability of 51-HA, but did render it unable to bind to CRBC. It is possible that Glu 190/9-OH interaction might be essential for the binding of the HA to CRBC. Previously, an investigation of the asialo portion of receptor microdomains, using natural and synthetic sialosides, indicated that there was no specific recognition of certain asialo portions of the sialosides and that the magnitude of the contribution of the asialo portion varied, depending on the virus type, subtype, and strain (Pritchett et al., 1987; Matrosovich et al., 1993; Gambaryan et al., 1995) . On the basis of our findings, we could propose a hypothesis that an amino acid change in E190D of HA possibly affected the distinction between asialo portions of sialyloligosaccharides on derivatized and on native CRBC but not between terminal sialic acid linkages. Although we found that the SA␣2,6Gal␤1,4GlcNAc sequence on certain sialyloligosaccharides of derivatized CRBC was necessary for receptor binding by 51/92, a contribution of more distant parts of the receptor molecule remains to be defined.
Cultivation of influenza viruses in different host cells is known to lead to a number of receptor-binding variants. Gambaryan et al. as well as others previously indicated that adaptation to the host cell environment was closely related to the degree to which the virus could bind to the cell, and this in turn was affected by host-dependent glycosylation of HA or by amino acid changes adjacent to the HA receptor-binding site (Gambaryan et al., 1997 (Gambaryan et al., , 1998 (Gambaryan et al., , 1999 Govorkova et al., 1999) . Ito et al. (1997b) reported differences in the amount of SA␣2,3Gal and SA␣2,6Gal in different host cells and demonstrated that the absence of the SA␣2,6Gal moiety in egg allantois of chicken eggs could be correlated with the appearance of host cell variants with altered receptor specificity. They also showed that MDCK cells contain both SA␣2,3Gal and SA␣2,6Gal, and therefore human influenza viruses passaged in MDCK cells retained their authentic receptor-binding character without any amino acid substitutions in HA. Since the ChϪ viruses investigated in this study were isolated directly in MDCK cells, their receptor-binding ability should be authentic and not the result of selection for preferential-binding variants. ChϪ viruses hardly grow in embryonated chicken eggs and an egg-adapted virus could not be obtained by three passages in eggs. However, we previously obtained an egg-adapted form from an H1N1 virus, which did not agglutinate CRBC, by passaging this virus three times in eggs (Morishita et al., 1996) . The egg-adapted virus gained the ability to agglutinate CRBC and acquired an amino acid change in its HA. When one considers that vaccine strains are usually grown in eggs, it is possible that these viruses were egg-adapted and had developed a receptor-binding specificity that was different from their intrinsic specificity.
In the current study, using derivatized RBC and HPLC, we examined the altered receptor-binding ability of recent human influenza viruses which do not agglutinate CRBC. The biological significance of this change in binding ability remains to be elucidated. To investigate this biological significance, we are continuing to examine amino acid substitutions in the receptor-binding site of circulating human influenza virus HA and their effect on receptor recognition and pathogenicity in infected individuals.
MATERIALS AND METHODS
Viruses
The H3N2 human influenza viruses, 51/92, 48/93, 18/ 95, 46/96, 30/97, 11/98 , and 3/99, were derived from clinical samples (throat swabs). All viruses used in this study were grown in MDCK cells. The virus-infected cells were maintained in Dulbecco's minimum essential medium (DMEM) supplemented with 0.3% bovine albumin solution and acetyltrypsin (2.5 g/ml). Viruses were purified by plaque purification in MDCK cells in the presence of 2.5 g/ml acetyltrypsin. MDCK cells and Cos cells were grown in DMEM supplemented with 7% fetal calf serum.
HA cDNA cloning
The cDNA of the HA gene was prepared by reverse transcription of virus RNA using Moloney murine leukemia virus reverse transcriptase (GIBCO BRL, Life Technologies, Gaithersburg, MD) and HA-specific primers H3HA-1 (5Ј-CCGGGAATTCAGCAAAAGCAGGGG-3Ј) with an EcoRI site built in (underlined) for HA1, and H3HA-645 (5Ј-GAACAAACCAACCTATAT-3Ј) for HA2. The cDNA was amplified with additional antisense primers H3HAR-1140 (5Ј-GCCTGAAACCGTACCAACC-3Ј) for HA1 and H3HAR-1765 (5Ј-CCGGTCTAGAAGTAGAAACAAGGGT-3Ј) with XbaI site built in (underlined) for HA2, and amplification was carried out by means of a polymerase chain reaction (PCR) using Takara LA Taq polymerase (Takara Biomedicals, Japan). The PCR fragments of HA1 and HA2 were digested with EcoRI and PstI and PstI and XbaI, respectively. Then both fragments were cloned into the EcoRI and XbaI sites of a mammalian expression vector, pME18S, containing the origin of SV40 and the SR␣ promoter, which is composed of the SV40 early promoter and R and part of the U5 sequence of the long terminal repeat of human T-cell leukemia virus type 1 (Takebe et al., 1988; Morishita et al., 1996) . The resulting plasmids carrying HA cDNA (pMEHAs) were used for experiments of the expressed HA.
HA expression and hemadsorption
Cos cells grown on glass coverslips (18-mm diameter) were transfected with 250 ng of expression plasmid carrying HA cDNA (pMEHA) using Lipofectamine reagent (GIBCO BRL) according to the manufacturer's pro-tocol. At 48 h after transfection with pMEHA DNA, the cells were washed with DMEM and hemadsorption tests were performed with a freshly prepared suspension of CRBC and HRBC at 4°C for 0.5 h. Unadsorbed erythrocytes were washed out with DMEM and hemadsorptionpositive cells were observed under a phase-contrast microscope. For quantification, the Cos cells and erythrocytes were lysed with distilled water. Cell debris was removed by centrifugation, and the released hemoglobin was measured by absorbance at 540 nm as described previously (Ohuchi et al., 1995) . Sialidase treatment was performed by incubation of the Cos cells with 1 unit/ml of VCNA solution (Boehringer Mannheim, Gmbh, Mannheim, Germany) at 37°C for 1 h as described previously (Ohuchi et al., 1995) .
Cell-surface fluorescence analysis
For detection of the cell-surface expression of HA, 4 ϫ 10 5 Cos cells expressing HA were detached from cover glasses with EDTA and trypsin, washed with PBS containing 1% BSA, and fixed with 1% paraformaldehyde at room temperature for 20 min with gentle agitation. The fixed cells were stained with anti A/Udorn/72 hyperimmune rabbit serum, which could recognize both 51-HA and CM-HA, and fluorescein-conjugated goat anti-rabbit immunoglobulin G antibody. After suspension in 1 ml of PBS, cells were subjected to fluorescence-activated cell sorting (Becton-Dickinson, Rutherford, NJ) analysis.
Construction of chimeric HA and mutant HA
The cDNA of 51-HA was partially replaced with the corresponding region of CM-HA at the respective restriction enzyme recognition sites to construct three HA chimeras between 51-HA and CM-HA (Fig. 2) . cDNAs of 51-HA and CM-HA were digested with XbaI and BsiHKAI, and the fragments were cloned into the EcoRI and XbaI sites of pME18S.
Site-specific mutations in HA (51-mut1 to mut5 and CM-mut1 to mut5) were generated by PCR with mutant primers by site-specific mutagenesis using a Takara LA PCR in vitro mutagenesis kit (Takara Biomedicals) according to the manufacturer's protocol. Mutagenic primers used for 51-mut1 to mut5 were 5Ј-CGAGCATCAGG-GAGAGTCACAG-3Ј, 5Ј-CGGACCGTGAGCAAACCAAC-CTATATGTTCGAG-3Ј, 5Ј-CGGACCGTGAGCAAACCA-GCCTATATGTTCG-3Ј, 5Ј-AGTGAGCAAACCAGCCTATAT-GTTCG-3Ј, and 5Ј-GGACCGTGACCAAACCAGCCT-ATATG-3Ј, respectively; and those used for CM-mut1 to mut5 were 5Ј-GTTCGAGAATCAGGGAGAGTCACAG-3Ј, 5Ј-CAGACAGTGACCAAACCAGCCTATATGTTCGA-3Ј, 5Ј-CAGACAGTGACCAAACCAACCTATATGTTC-3Ј, 5Ј-CAGA-CAGAGACCAAACCAACCTATATG-3Ј, and 5Ј-CAGACAGT-GAACAAACCAACCTATATG-3Ј, respectively. After the sequences were confirmed, the fragments were inserted into corresponding regions of the pMEHAs.
Measurement of sialic acid content
CRBC and HRBC were incubated for 1 h at 37°C in a 100-l suspension (10% v/v) in PBS containing 50 mU of the respective sialidase as described previously (Paulson and Rogers, 1987; Schultze et al., 1990) . Sialidases from Vibrio cholerae and Arthrobacter (Boehringer Mannheim) hydrolyze terminal N-or O-linked sialic acids in ␣2,3, ␣2,6, or ␣2,8 linkage with glycoconjugates, which ensures their complete removal from these glycoconjugates. ␣2,3-Sialidase from Salmonella typhimurium LT2 (Takara Biomedicals) and Newcastle disease virus (NDV) (Boehringer Mannheim) specifically cleaves a terminal sialic acid in ␣2,3 linkage with N-or O-glycosidically bound oligosaccharide chains of glycoproteins and glycolipids, but does not cleave sialic acids in ␣2,6 linkage. As a control, RBC suspension was also incubated without sialidase. After the incubation, the RBC suspension was centrifuged and the supernatant was used for quantitative determination of the sialic acid content of these cells using HPLC with fluorescence detection (Hara et al., 1989) . Briefly, the sialic acids in the supernatant were derivatized with 1,2-diamino-4,5-methylenedioxybenzene (DMB) and the derivatives were then separated on a reverse-phase Palpak Type R column (0.46 ϫ 25 cm; Takara Biomedicals) column. The mobile phase was a mixture of acetonitrile-methanol-water (9:7:84, v/v) and the flow rate was 0.9 ml/min. The column temperature was maintained at 30°C. The DMB derivatives of sialic acids were detected with a fluorescence detector (Model RF-10A; Shimadzu Corp., Japan), which was operated at an emission wavelength of 448 nm and an excitation wavelength of 373 nm. DMB-NeuAc and DMB-NeuGc were used as standards. Linear relationships were observed between the peak height and the amount of each neuraminic acid up to a concentration of 10 pmol/50 l.
Preparation of resialylated erythrocytes
CRBC were sialylated essentially as previously described (Paulson and Rogers, 1987; Shultze et al., 1990) using Gal␤1,4GlcNAc ␣2,6-sialyltransferase or Gal␤1,3/ 4GlcNAc ␣2,3-sialyltransferase (Carroll et al., 1981) . Suspensions (10%) of CRBC or HRBC were prepared in PBS and 100-l aliquots of these suspensions were incubated with 50 mU of VCNA and ␣2,3-sialidase from S. typhimurium LT2. After 1 h at 37°C, the erythrocytes were washed twice with PBS and resuspended in 50 l PBS containing 1% bovine serum albumin. After addition of 2.5 mU of Gal␤1,4GlcNAc ␣2,6-sialyltransferase (Boehringer Mannheim) or Gal␤1,3/4GlcNAc ␣2,3-sialyltransferase (Calbiochem Biosciences, La Jolla, CA) and CMP-Nacetylneuraminic acid (Sigma Chemical, St. Louis, MO) to give a final concentration of 1.5 mM, the erythrocytes were incubated at 37°C for 4 h. The erythrocytes were washed three times, resuspended in 2 ml of PBS, and used for HA titration. For quantitative determination of sialic acids in the derivatized erythrocytes, sialic acids were released with VCNA, labeled with 1,2-diamino-4,5-methylenedioxybenzene, and then subjected to HPLC analysis as described above.
